GUIDELINE FOR GOOD CLINICAL PRACTICEE6(R1)
ICH Tripartite Guideline was agreed upon by the US, EU, and Japan for Good Clinical Practice (GCP) under the Efficacy category.
GUIDELINE FOR GOOD CLINICAL PRACTICEE6(R1)
ICH Tripartite Guideline was agreed upon by the US, EU, and Japan for Good Clinical Practice (GCP) under the Efficacy category.
§314.53 Submission of patent information.
What must be disclosed? How does 314.53 relate to the CTD?
§314.3 Definitions.
Note the definitions for the application. What terms are important to understand before starting the application?
What are the ICH guidelines categories for each CTD Module? Example: Module 5 contains ICH M4E(R1)
What do these codes mean?
applicant
Who is the applicant? Hint: Go back to 21 CF 314.3 Definitions.
(a) Application form
What is the required form the FDA wants completed and signed?